DOT Speaks Out About Cannabidiol Products

March 6, 2020 09:00:17

Cannabidiol has only been around for a few years, but it has received an insane amount of mainstream media attention. Commonly known as CBD, the chemical is extracted from hemp and it’s said to have tons of beneficial medicinal properties. The CBD craze caught on when the 2018 Farm Bill legalized industrial hemp and its extracts. Within a year, cannabidiol was worth millions of dollars in sales.

Despite being extremely popular and accessible, CBD isn’t properly regulated yet. The FDA has repeatedly stated that CBD isn’t generally recognized as safe, going so far as to send warning letters to companies making unsubstantiated medical claims on their products. Still, thousands of CBD products fill the shelves, leading many people into believing…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.